Stocktoria

ORAMED PHARMACEUTICALS INC. ORMP

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2002-04-01 · LEI

ORAMED PHARMACEUTICALS INC. statistics & valuation

Market cap$191.1M
P / E3.0×
P / S95.6×
P / B1.0×
Net margin3202.5%
Return on equity32.1%
FCF margin-457.7%
Return on capital-7.1%
Graham number +195.2%$12.61

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($12.61); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-1710.50% -426.70% -519.70% -531.10% -424.80% -850.50% -1352.60% 379.70% 3202.50% 2016201720182019202020212022202320242025
Gross margin (%)
0.70% 2016201720182019202020212022202320242025
Operating margin (%)
-1561.60% -438.60% -552.30% -541.30% -433.80% -896.20% -1502.00% -1176.80% -754.40% 2016201720182019202020212022202320242025
Return on equity (%)
-41.90% -54.50% -40.90% -74.00% -35.00% -19.70% -24.10% 3.10% -13.00% 32.10% 2016201720182019202020212022202320242025
Shares outstanding
13.2M 13.7M 17.4M 17.4M 23.7M 35.3M 39.6M 40.6M 40.9M 42.4M 2016201720182019202020212022202320242025
Net debt ($)
$6.4M $6.3M -$64.7M -$40.4M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-25.60% -27.10% -26.90% -41.40% -25.80% -18.00% -22.60% 2.30% -12.30% 27.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
724.80% -237.70% -598.70% -479.30% -462.10% -797.50% -1051.20% -787.20% -457.70% 2016201720182019202020212022202320242025
Debt / equity (×)
0.37× 0.50× 0.11× 0.00× 2016201720182019202020212022202320242025
EPS ($)
-$0.94 $0.14 -$0.48 $1.50 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin0.7%—————————
Operating margin-754.4%—-1176.8%-1502.0%-896.2%-433.8%-541.3%-552.3%-438.6%-1561.6%
Net margin3202.5%—379.7%-1352.6%-850.5%-424.8%-531.1%-519.7%-426.7%-1710.5%
FCF margin-457.7%—-787.2%-1051.2%-797.5%-462.1%-479.3%-598.7%-237.7%724.8%
Return on assets27.7%-12.3%2.3%-22.6%-18.0%-25.8%-41.4%-26.9%-27.1%-25.6%
Return on equity32.1%-13.0%3.1%-24.1%-19.7%-35.0%-74.0%-40.9%-54.5%-41.9%
Debt / equity———0.00×0.11×—0.50×0.37×——
Current ratio6.9825.193.0627.3414.278.936.286.823.938.62

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.